Catalio Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Catalio Capital Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-426,551	Closed	-$8.59M	–	44
2026 Q1	$8.59M	Buy	+426,551	New	+$6.87M	1.79%	22

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Catalio Capital Management's KALV Position: Q2 2026 in Review

Catalio Capital Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 426,551 shares — an estimated $8.59M sold.

Catalio Capital Management first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $8.59M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Catalio Capital Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Catalio Capital Management sold 426,551 KalVista Pharmaceuticals shares in Q2 2026, an estimated $8.59M.
Catalio Capital Management first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Catalio Capital Management's KalVista Pharmaceuticals position peaked at $8.59M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Catalio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.